Michael Palovich, Ph.D.

Michael Palovich, Ph.D., is a Vice President, Head of Chemistry, Deerfield Discovery and Development, and joined the Firm in 2024. Prior to Deerfield, Dr. Palovich was the Vice President of Medicinal Chemistry and Applied Molecule Technologies for Recursion Pharmaceuticals and the Chief Scientific Officer and Head of Drug Discovery for Cyclica which was bought by Recursion in 2023. Before these positions, he spent 24 years with GSK, in a variety of roles, most recently as a Senior Director, Medicinal Chemistry. Dr. Palovich holds a B.S. in Organic Chemistry from Allegheny College and a Ph.D. in Organic Chemistry from the University of Pittsburgh.